2-Methoxy-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 97%, 1g

Base de support, 1 pièce

3-Chloro-2,4-difluoropyridine, 95.0%, 100mg

(1,2,4-oxadiazol-3-ylmethyl)amine hydrochloride, 95.0%, 5g

2-(Piperazin-1-yl)propanenitrile dihydrochloride, 98%, 250mg

Methyl 4-(difluoromethoxy)-3-hydroxybenzoate, 97%, 1g

2'-Methoxybiphenyl-3-carboxylic acid, 98.0%, 5g

4-Fluorobenzylisocyanide, 1g

(S)-2-((tert-Butoxycarbonyl)amino)-2-(thiophen-2-yl)acetic acid, 95.0%, 1g

3-BROMO-2-METHYLBENZOYL CHLORIDE, 97.0%, 25g

Ethyl 2,7-dimethylimidazo[1,2-a]pyridine-3-carboxylate, 95.0%, 1g

1-(2-furyl)-N-(2-furylmethyl)methanamine hydrochloride, 95.0%, 1g

Colonne capillaire GC ROTI®Cap-FFAP, 30 m, 0,32 mm, 0,50 µm, 1 pièce(s)